Health · 3 views
New Zealand drugs regulator approves use of MDMA to treat severe PTSD
New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with sever…
AI Summary
Two psychiatrists in New Zealand received approval on Friday to prescribe pharmaceutical‑grade MDMA to patients with severe post‑traumatic stress disorder. The decision follows Australia’s 2023 approval of psychedelics for PTSD and treatment‑resistant depression.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Is poor sleep contributing to the country's weight issues?Continue reading
- People affected by cancer need a stronger voice in shaping generative AI for oncology, review findsContinue reading
- Do you hate being middle-aged? NPR's Allison Aubrey wants to change thatContinue reading
- 'The health system in Nepal is not prepared for this'Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow